John R. Moore, VP, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 75,384 shares at $7.00 ($529K) on 2013-08-01, disclosed to the SEC on 2013-08-02.
Scheduled sale ($529k) by VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 31,500 | $221K | 41.7% |
| 2 | $7.03 | 43,884 | $309K | 58.3% |
| Total | $7.02 avg | 75,384 | $529K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |